EraCal Therapeutics
PrivateLast Round
Seed
Oct 16, 2019
Total Funding Raised
$1.14M
Company Overview
EraCal Therapeutics is a biotechnology company that develops drugs to treat metabolic syndrome and obesity using its in-vivo screening platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EraCal Therapeutics Comparables
Compare EraCal Therapeutics with similar companies based on industry and business-model similarity.
EraCal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 16, 2019 | ||||
| Grant | Feb 1, 2019 |
EraCal Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Zurich | Seed |
| Redalpine | Seed |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors increased 151% MoM, reaching 1.1K.
- Jun 1, 2025
Monthly visitors grew 91% MoM.
EraCal Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EraCal Therapeutics's valuation, stock price, and market status.